Food and Drug Administration
Dermatologic and Ophthalmic Drugs Advisory Committee Meeting
Slides
May 23, 2002
Alefacept BLA Review Committee, Dr. Ezio Bonvini, MD, et. al. htm ppt
Alefacept Overview, Biogen, Inc. htm ppt
Clinical Efficacy Overview, Dr. Burt Adelman, MD, et. al., Biogen htm ppt
Safety Overview, Dr. Gloria Vigliani, MD, Biogen htm ppt
Alefacept Risk Benefit Profile, Dr. Mark Lebwohl, MD, Biogen htm ppt
Indications and Uses, Dr. Marzella, MD, FDA htm ppt